Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration.
Khanani AM, Guymer RH, Basu K, Boston H, Heier JS, Korobelnik JF, Kotecha A, Lin H, Silverman D, Swaminathan B, Willis JR, Yoon YH, Quezada-Ruiz C. Khanani AM, et al. Among authors: guymer rh. Ophthalmol Sci. 2021 Nov 17;1(4):100076. doi: 10.1016/j.xops.2021.100076. eCollection 2021 Dec. Ophthalmol Sci. 2021. PMID: 36246941 Free PMC article.
New treatments in age-related macular degeneration.
Hooper CY, Guymer RH. Hooper CY, et al. Among authors: guymer rh. Clin Exp Ophthalmol. 2003 Oct;31(5):376-91. doi: 10.1046/j.1442-9071.2003.00683.x. Clin Exp Ophthalmol. 2003. PMID: 14516424 Review.
Flicker perimetry losses in age-related macular degeneration.
Phipps JA, Dang TM, Vingrys AJ, Guymer RH. Phipps JA, et al. Among authors: guymer rh. Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3355-60. doi: 10.1167/iovs.04-0253. Invest Ophthalmol Vis Sci. 2004. PMID: 15326161
401 results